LumaBio I LP
LumaBio I LP is a venture capital fund based in New York, New York. According to its most recent Form D, filed Sep 9, 2026, it has sold $410,000,000 of interests to 63 investors since its first sale in Jul 2023. The filing does not set a minimum investment. It relies on the Section 3(c)(7) exclusion, so investors generally must be qualified purchasers. The offering uses Rule 506(b), which does not permit general solicitation. Related persons named in the filing include Luma Group Advisor LLC; Themasap Khan; Luma Group TopCo LLC.
- Total raised
- $410,000,000Cumulative sales reported on Form D
- Investors
- 63
- First sale
- Jul 25, 2023
- Minimum investment
- None set
- Who can invest
- Qualified purchasersSection 3(c)(7): generally $5M+ in investments
- Offering exemption
- Rule 506(b)No general advertising
- Key people and entities
- Luma Group Advisor LLC; Themasap Khan; Luma Group TopCo LLC
- Latest Form D
- Sep 9, 2026
From SEC filings, not verified. This page republishes the fund's Form D as filed. It is not an offer, solicitation or recommendation, and AltMountain has not reviewed the fund. “Raised” is cumulative sales, not current assets or performance. Returns are not part of SEC filings. Private funds are speculative, illiquid and generally limited to accredited investors or qualified purchasers. Full disclosures · Request a correction
Questions about LumaBio I LP
What is the minimum investment for LumaBio I LP?
LumaBio I LP's latest Form D, filed Sep 9, 2026, does not set a minimum investment. Managers can still require one in the offering documents.
Who can invest in LumaBio I LP?
LumaBio I LP is generally open only to qualified purchasers (generally individuals with at least $5 million in investments), because it relies on Section 3(c)(7). It uses Rule 506(b), which does not allow general advertising.
How much has LumaBio I LP raised?
LumaBio I LP reports $410,000,000 sold from 63 investors on its Form D filed Sep 9, 2026. This is cumulative sales since the offering began, not current assets or performance.
Where is LumaBio I LP based?
LumaBio I LP is based in New York, New York and is managed by Luma Group.
When did LumaBio I LP launch?
LumaBio I LP reports its first sale in Jul 2023.
Size compared with every venture capital fund
Raised more than 99% of the 1,252 venture capital funds based in New York, and more than 100% of all 15,160 that report sales.